Strategic Initiative

Slingshot members are tracking this corporate initiative:

Philogen announces expanded research and development agreement with Abbvie

Source Link:: http://www.philogen.com/media/all_news/Press%20Release%20Philogen%20AbbVie%202016_final.pdf

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

ABBV

Community voting in process

Philogen S.p.A.

Community voting in process

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Philogen has entered into a second collaboration with AbbVie to discover and develop novel types of armed antibody products.

No financial details of the agreement were released.

http://www.philogen....

Management Comment ‘We are excited to expand our collaboration with AbbVie, a leader in the field of antibody therapeutics’’ commented Dr. Duccio Neri, Philogen’s CEO. ‘The first agreement between the companies focused on osteoarthritis, and we are continuing to explore the shared scientific strengths of both companies.’’ No financial details of the agreement were released.

http://www.philogen....

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Feb 15, 2016

Projected Implementation:

Q1, 2016

Relevance Tracked Until:

Q4, 2016

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords Development, Agreement, Research